Pages that link to "Q71899660"
Jump to navigation
Jump to search
The following pages link to Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180) (Q71899660):
Displaying 14 items.
- Bioflavonoids as poisons of human topoisomerase II alpha and II beta (Q24627367) (← links)
- Collision of Trapped Topoisomerase 2 with Transcription and Replication: Generation and Repair of DNA Double-Strand Breaks with 5' Adducts (Q26744712) (← links)
- Drugging topoisomerases: lessons and challenges (Q27000099) (← links)
- Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide (Q28534943) (← links)
- Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. (Q33391858) (← links)
- Use of a rapid throughput in vivo screen to investigate inhibitors of eukaryotic topoisomerase II enzymes (Q33692759) (← links)
- DNA break mapping reveals topoisomerase II activity genome-wide (Q34072605) (← links)
- XK469, a selective topoisomerase IIbeta poison (Q35736271) (← links)
- Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. (Q35865072) (← links)
- DNA topoisomerase II selects DNA cleavage sites based on reactivity rather than binding affinity. (Q35893882) (← links)
- Iron chelators with topoisomerase-inhibitory activity and their anticancer applications (Q36568915) (← links)
- Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. (Q37219286) (← links)
- C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo (Q40127799) (← links)
- Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives (Q58607163) (← links)